Cardiawave is presenting the 30-day follow-up results from its "Valvosoft® Pivotal Study" on the treatment of severe symptomatic aortic valve stenosis | Region
LEVALLOIS-PERRET, France--(BUSINESS WIRE)--Apr 5, 2024--
Source: eagletribune.com
Stay updated with breaking news from Eric Van Belle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LEVALLOIS-PERRET, France--(BUSINESS WIRE)--Apr 5, 2024--
Directly comparing PARTNER 3 and Evolut Low Risk results is like “discussing reincarnation,” one prominent statistician warns.
An observational study shows no short-term harm with these acute bleeds but doesn’t rule out possible cognitive decline.